Risultati della ricerca

• 81. SEMINARIO/Ricerche su oncobiologia sperimentale (18%)

  8-mar-2013 13.52.17

  model of breast cancer herceptin-resistance - dott. Gianluca Di Cara; • Occurrence of mmp-9 and mmp-2 in breast cancer patients and possible correlations with mammographic stromal density - dott.ssa Maria Rita Marabeti; • Messages from exosome-like vesicles shed by breast cancer cells - dr.ssa

• 82. brochure29-09-2023_compressed (18%)

  6-ott-2023 10.01.52

  Heredo-familial breast carcinoma dermatological symptoms, and in some cases neurodevelopmental d ... Palermo Medical Director Breast Unit F. Verderame Director Department of Pharmacy AOOR Villa Sofia ... Dirigente Medico Breast Unit correlati al PTEN Partecipanti e Relatori Francesca CATALANO Università “Tor

• 83. PhD Thesis topics (18%)

  14-lug-2023 13.44.13

  transition in breast cancer Francesco Cancilla MASSIMO MARCO PhD Thesis topics - Cycle XXXVII articolo ... and Breast cancer tissues by multiomic analyses De Luca Giuseppe Biomimetic modules for artificial tissues Filiciani Sandra Use of partially absorbable meshes in reconstructive and aesthetic breast

• 84. Verbale riunione Commissione Restate al Dichirons 21.01.2022 APPROVATO (18%)

  4-ott-2023 10.09.13

  of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious 4 ... Significance in Breast/Ovarian Cancer: Mysterious 4 Alessia Fiorino Dottorando Signals From the Genome ... of Uncertain Significance 2. 5 4 3 12 Fiorino in Breast/Ovarian Cancer: Mysterious Signals From the Genome

• 85. curriculum maggio 2022 Madonia (18%)

  9-mag-2022 12.56.26

  in Breast/Ovarian Cancer: Mysterious Signals From the Genome. Fanale D, Fiorino A, Incorvaia L, Front ... /10.1016/j.jtho.2021.01.880 Population-based testing for hereditary breast and ovarian cancer ... .2020.08.1595 247P Population-based testing for hereditary breast and ovarian cancer in a cohort of 1,346

• 86. cv Sofia Cutaia (18%)

  8-mar-2022 11.30.20

  ; March 01, 2021 “BRCA1/2 pathogenic variants in triple- negative versus luminal-like breast cancers ... . “Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and ... (AIOM). TJ-Abstract book AIOM 2019 “Denosumab for bone health in prostate and breast cancer patients

• 87. Dottorato (18%)

  21-giu-2017 11.26.42

  breast cancer phenotype Rodolfo Mauceri Dipartimento DICHIRONS Plesso Odontostomatologia II piano AOUP ... - patologiche della malattia. Characterization of DNA methylation profiles in Male Breast Cancer patients ... di rischio ad esso correlati e valutazione dell'efficacia del trattamento chirurgico" Breast

• 88. DonneCheParlanoDiDonne_2022-10-27_Locandina (18%)

  24-ott-2022 8.18.48

  , N. Scibetta I SESSIONE ADVANCED BREAST CANCER HER2+ 19:15-19:30 Chiusura della prima giornata ... ADVANCED BREAST CANCER ER+ HER2- 15:50-16:20 Real life MODERATORI: F. Catalano, M.R. Valerio ... -territorio CONDUCE: F. Catalano, D. Sambataro, R. Camarda II SESSIONE ADVANCED BREAST CANCER TRIPLE

• 89. cv_piana (18%)

  16-feb-2021 15.40.59

  N 2020 Overview of radiomics in breast cancer diagnosis and prog- nostication The Breast 49 74 5 ... F, Brignone M, Bozza G, Aramini R, and Piana M 2010 A vi- sualization method for breast cancer ... 32 8. Miyakawa M, Sugawara K, Bertero M and Piana M 2002 Computa- tional imaging of the breast and

• 90. writing (18%)

  5-mag-2013 22.38.20

  , kidney, gallbladder (in women), breast (in answer tphoestmenopausal women), and colon (particularly ... Characteristics of the Women Who Underwent Radical Mastectomy and Those Who Underwent Breast-Conserving Therapy. Veronesi et al. Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer NEJM 347:1227-1232; October 17, 2002

• 91. 59 bando (18%)

  3-dic-2019 12.58.23

  ” - Title: “The role of altered mechanotransduction in Breast Cancer metastasis” - Descrizione ... e la stratificazione del paziente. - Description: Breast cancer is the most frequent tumor worldwide ... or treat metastasis are currently unsolved challenges in the clinical management of metastatic breast ... interactions. Results hold the promise to reveal new therapeutic strategies for metastatic breast

• 92. 3989-2014_bandoborsa_vitabile (18%)

  21-nov-2014 10.50.21

  del 27.02.2014, con cui il progetto denominato "BD4 BREAST" è ammesso a finanziamento; Visto ... alla attivazione di n° 1 borsa di studio post-lauream da far gravare su BD4 BREAST - Unframework Intelligente ... 21 - BORSE DI STUDIO FINALIZZATE ALLA RICERCA mammografiche”, da far gravare su BD4 BREAST ... mammografiche”, da far gravare su BD4 BREAST - Unframework Intelligente per l'Analisi di Big Data

• 93. bando_bs_143-2022_todaro f.to (18%)

  12-set-2022 9.03.22

  genotype to phenotype for breast and colorectalcancerstemcells: implications and perspectives ... e per l’importo di € 18.000,00, da far gravare su: Progetto “Mapping genotype to phenotype for breast and ... -chirurgiche”, da far gravare su: Progetto “Mapping genotype to phenotype for breast and ... -chirurgiche”, da far gravare su: Progetto “Mapping genotype to phenotype for breast and

• 94. cv 2023 Carreca Anna Paola (18%)

  28-mar-2023 15.24.54

  S.Margherita del Belice (Ag). Breast and Lung Cancer in the elderly – Update and Future; 29 June – 1 ... IN ELDERLY ADVANCED BREAST CANCER PATIENTS: THE PROPOSAL FOR AN EFFECTIVE AND SAFE COMBINED TREATMENT ... IN PRE-TREATED BREAST CANCER ELDERLY PATIENTS WITH PULMONARY METASTASES.. In Annals of Oncology ... outcomes in elderly breast cancer women. Paper presented at 96th Annual Meeting American

• 95. CV-Europass-20161121-Galvano-IT_b (18%)

  21-nov-2016 10.32.19

  advanced or metastatic Breast Cancer Studio clinico multicentrico, a braccio singolo, in aperto ... , Cicero G, Bazan V, Castorina S, Russo A. Triple negative breast cancer: shedding light onto the role ... . Combined treatment with fulvestrant plus capecitabine in elderly advanced breast cancer (EABC ... neutropenia in patients treated for sarcoma, breast and lung cancer. I supplementi di tumori, vol 10

• 96. Mahafarin Maralani_CV (18%)

  27-feb-2020 12.24.59

  , Cluj-Napoca, Romania. o Contributed in ongoing projects on new drug treatments for breast cancer ... with focus on recent updates in prevention, diagnosis and treatment of breast cancer, 8-10 November ... therapy in triple negative breast cancer model”, Cornelia Braicu, Eve Ponthière, Mahafarin Maralani ... , an in vitro model for triple negative breast cancer”, L Budisan, C Braicu, E Ponthière, M Maralani, V

• 97. cv santini (15%)

  14-apr-2020 11.09.52

  I. Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice ... treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label ... occurrence in breast cancer patients. PLoS One. 2011 Apr 29;6(4):e19234. doi: 10.1371/journal.pone

• 98. 3cl_cv castorina (15%)

  20-apr-2020 13.36.57

  of miRNA expression profile induced by short term starvation in breast cancer cells treated ... , Cicero G, Bazan V, Castorina S, Russo A. Triple negative breast cancer: shedding light onto ... profile help to identify novel targets for Zoledronic Acid in Breast Cancer? ONCOTARGET (2016), 7(20

• 99. cv cuda (15%)

  10-lug-2018 10.03.21

  of breast tumors arising in BRCA1 5083del19 founder mutation carriers (Componente di Unità ... ., Ricevuto, E., Costanzo, F.S., Cuda, G. Plasma proteomic profiling in hereditary breast cancer reveals ... of breast cancer interstitial fluids by TmT labeling, ltq-orbitrap velos mass spectrometry, and

• 100. cv_sabba (15%)

  14-apr-2021 10.47.56

  diabetes on breast cancer: current therapeutic measures of prevention Curr Drug Targets Immune Endocr ... neoplasia with particular reference to breast cancer: role of hormones, growth factors and specific ... C, Tafaro E Breast cancer: biological characteristics in postmenopausal type 2 diabetic women